How well do BNP levels correspond to response of CHF to therapy?
Metadata[+] Show full item record
B-type natriuretic peptide (BNP)-guided therapy does not alter all-cause hospitalization rates, quality of life, or overall survival compared with symptom-guided therapy, although it does appear to reduce the rate of systolic heart failure-related hospitalizations in patients younger than 74 years. (SOR B, based on a randomized controlled trial [RCT].)
Evidence-based practice 12, no. 12 (2009): 08-09